Recommendations for the Treatment of Children With Burkitt's Lymphoma

Last updated: August 13, 2024
Sponsor: French Africa Pediatric Oncology Group
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lymphoma

Marginal Zone Lymphoma

Hematologic Cancer

Treatment

OBSERVATIONAL

Clinical Study ID

NCT04425421
GFA LMB 2019
  • Ages < 18
  • All Genders

Study Summary

This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Clinical diagnosis of Burkitt's Lymphoma: all location. Diagnosis by cytology or histology. Not possible to follow all the treatment.

Exclusion

  • Exclusion Criteria:

Not a B Cell tumor. Child has been previously treated. Child has also another illness which would render the treatment incompatible. Parents refusal.

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: OBSERVATIONAL
Phase:
Study Start date:
November 01, 2020
Estimated Completion Date:
December 31, 2027

Study Description

This is the 4th Burkitt's Lymphoma (LMB) study by the GFAOP group. This study hopes to include at least 14 Sub Saharian countries some of whom have never participated in a LMB study. The evaluation of improvement in early diagnosis should be possible in this study. The study hopes to be able to evaluate children earlier, with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for children with a stage IV disease.

Connect with a study center

  • Hopital Yalgado Ouedraogo

    Ouagadougou, 03 BP 7022
    Burkina Faso

    Active - Recruiting

  • Cliniques Universitaires de Kinshasa

    Kinshasa, BP 12 KIN XI
    Congo, The Democratic Republic of the

    Active - Recruiting

  • Cliniques Universitaires de Lubumbashi (CUL)

    Lubumbashi, BP 1825
    Congo, The Democratic Republic of the

    Active - Recruiting

  • CHU de Treichville à ABIDJAN

    Abidjan,
    Côte D'Ivoire

    Active - Recruiting

  • HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona

    Antananarivo, BP 4150
    Madagascar

    Active - Recruiting

  • CHU Gabriel Touré (HGT)

    Bamako,
    Mali

    Active - Recruiting

  • Hôpital Aristide Le Dantec

    Dakar, BP 3001
    Senegal

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.